http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-37831-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a2d85d11c9516b41f0aadb58da50bd9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2008-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_218bc2b28a9321cd111940188ed08b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c0ab354004beffd3913c5332e32012c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d8131243fb77bf06d190483bb17155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87fd2da408863395e4e465f1522e21e7
publicationDate 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-37831-U
titleOfInvention METHOD OF RELATED IMMUNOTHERAPY ON THE BACKGROUND OF RADIATION THERAPY OF PATIENTS WITH BREAST CANCER
abstract Method for concomitant immunotherapy against radiation therapy of breast cancer patients, including evaluation of hematologic and immunological parameters of the organism with subsequent elimination of immune disorders by immunotropic drugs, additionally determine circadian rhythms of immune cells, immune cells G, circulating immune complexes and indicators of phagocytic activity of neutrophils, and immune disorders are eliminated by the combined use of drugs "Cycloferon", "Polyoxidone s "," Melatonin "according to the scheme:" Cycloferon "in 2 ml of 12.5% solution intramuscularly a day - 10 injections," Polyoxidonium "6 mg intramuscularly once every four days - 5 injections , "Melatonin" 6 mg per os once daily for 30 min. to sleep within 24 days [The method of accompanying immunotherapy on the background of radiation therapy for patients with breast cancer involves the assessment of hematological and immunological parameters of the body with the subsequent elimination of immune disorders using immunotropic drugs. In addition, circadian rhythms of immune cells, daily fluctuations of melatonin excretion, levels of immunoglobulins A, M, G, circulating immune complexes and indicators of phagocytic activity of neutrophils are further determined. Immune disorders are eliminated by the combined use of the drugs "Cycloferon", "Polioxidonium", "Melatonin" according to the scheme: "Cycloferon" with 2 ml of 12.5% solution intramuscularly every other day - 10 injections, "Polioxidonium" with 6 mg intramuscularly every four days - 5 injections, "Melatonin" 6 mg per os once daily for 30 minutes before going to bed for 24 days.
priorityDate 2008-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128

Total number of triples: 18.